Publication | Closed Access
Anthelmintic drug niclosamide enhances the sensitivity of chronic myeloid leukemia cells to dasatinib through inhibiting Erk/Mnk1/eIF4E pathway
23
Citations
28
References
2016
Year
Hematological MalignancyOncologyErk/mnk1/eif4e PathwayMedicineMalignant Blood DisorderPharmacotherapyAnti-cancer AgentPharmacologyRadiation OncologyDrug DiscoveryAnthelmintic Drug NiclosamideMyeloid Neoplasia
| Year | Citations | |
|---|---|---|
Page 1
Page 1